Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Raquel De Paz"'
P680: PONATINIB 15 MG AS CONSOLIDATION PRIOR TO TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA
Autor:
Valentin Garcia Gutierrez, Juan Carlos Hernandez-Boluda, Luis Felipe Casado Montero, M Teresa Gómez Casares, Rosa Ayala Diaz, Blanca Xicoy Cirici, Francisca Ferrer-Marín, Guillermo Ortí, Raquel De Paz Arias, Santiago Ossorio Prendes, Raúl Pérez López, Elvira Mora Castera, Concepcion Ruiz Nuño, Antonio Jimenez, Concepcion Boque Genovard, Magdalena Sierra, Joaquín Martinez-Lopez
Publikováno v:
HemaSphere, Vol 7, p e77404fb (2023)
Externí odkaz:
https://doaj.org/article/36457bc182dc4616965e2e0870a3656d
Autor:
Karima Al-Akioui Sanz, Carlos Echecopar Parente, Cristina Ferreras, Marta Menéndez Ribes, Alfonso Navarro, Carmen Mestre, Laura Clares, José Luis Vicario, Antonio Balas, Raquel De Paz, Eduardo López Granados, Elena Sánchez Zapardiel, Carlos Jiménez, María López-Oliva, Esther Ramos, Francisco Hernández-Oliveros, Antonio Pérez-Martínez
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundImmunocompromised patients are susceptible to high-risk opportunistic infections and malignant diseases. Most antiviral and antifungal drugs are quite toxic, relatively ineffective, and induce resistance in the long term. The transfer of pa
Externí odkaz:
https://doaj.org/article/1686827fd5484660b2e2b5b3552ae8d2
Autor:
Valentín Garcia-Gutiérrez, Alejandro Luna, Juan M. Alonso-Dominguez, Natalia Estrada, Concepcion Boque, Blanca Xicoy, Pilar Giraldo, Anna Angona, Alberto Alvarez-Larrán, Fermin Sanchez-Guijo, María José Ramírez, Elvira Mora, Patricia Vélez, Ana Rosell, Mercedes Colorado Araujo, Beatriz Cuevas, Miguel Sagüés, Montserrat Cortes, Manuel Perez Encinas, Luis Felipe Casado Montero, Melania Moreno Vega, Luis Serrano, Valle Gomez, Carmen Garcia-Hernandez, Sunil Lakhwani, Antonio Paz Coll, Raquel de Paz, Sara Suarez-Varela, Andrés Fernandez-Ruiz, Raul Perez Lopez, Almudena Ortiz-Fernández, Antonio Jiménez-Velasco, Juan Luis Steegmann-Olmedillas, Juan Carlos Hernández-Boluda
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/717b8583ea22422db39b5f3e0735ac0c
Autor:
José A. García-Marco, Javier López Jiménez, Valle Recasens, Miguel Fernández Zarzoso, Eva González-Barca, Nieves Somolinos De Marcos, M. Jose Ramírez, Francisco Javier Peñalver Parraga, Lucrecia Yañez, Javier De La Serna Torroba, Maria Dolores Garcia Malo, Guillermo Deben Ariznavarreta, Ernesto Perez Persona, M. Angeles Ruiz Guinaldo, Raquel De Paz Arias, Elena Bañas Llanos, Isidro Jarque, M. del Carmen Fernandez Valle, Ana Carral Tatay, Jaime Perez De Oteyza, Eva Maria Donato Martin, Inmaculada Perez Fernández, Rafael Martinez Martinez, M. Angeles Andreu Costa, Diana Champ, Julio García Suarez, Marcos González Díaz, Secundino Ferrer, Félix Carbonell, José A. García-Vela
Publikováno v:
Haematologica, Vol 104, Iss 11 (2019)
It has been postulated that monitoring measurable residual disease (MRD) could be used as a surrogate marker of progression-free survival (PFS) in chronic lymphocytic leukemia (CLL) patients after treatment with immunochemotherapy regimens. In this s
Externí odkaz:
https://doaj.org/article/fb9a08ed52534cc49c34466240ad698c
Autor:
Lucía Fernández, Adrián Fernández, Isabel Mirones, Adela Escudero, Leila Cardoso, María Vela, Diego Lanzarot, Raquel de Paz, Alejandra Leivas, Miguel Gallardo, Antonio Marcos, Ana Belén Romero, Joaquín Martínez-López, Antonio Pérez-Martínez
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Natural killer group 2D (NKG2D) is a natural killer (NK) cell-activating receptor that recognizes different stress-induced ligands that are overexpressed in a variety of childhood and adult tumors. NKG2D chimeric antigen receptor (CAR) T cells have s
Externí odkaz:
https://doaj.org/article/ba4d2ea6112c49d98f6f8eef30f4f95d
Autor:
Aurelio Lopez, Maria-Victoria Mateos, Albert Oriol, Marta Valero, Joaquín Martínez, Jose Ignacio Lorenzo, Montserrat Perez, Rafael Martinez, Raquel de Paz, Miguel Granell, Felipe De Arriba, M. Jesús Blanchard, Francisco Javier Peñalver, Jose Luis Bello, Maria Luisa Martin, Joan Bargay, Joan Blade, Juan Jose Lahuerta, Jesús F. San Miguel, Javier de la Rubia
Publikováno v:
Leukemia Research Reports, Vol 4, Iss 2, Pp 64-69 (2015)
We report the characteristics of relapse, treatment response, and outcomes of 145 elderly patients with multiple myeloma in first relapse after front-line treatment with VMP or VTP. Reappearance of CRAB symptoms (113 patients) and more aggressive for
Externí odkaz:
https://doaj.org/article/78674f08f0c94093ab27b31981a251e8
Autor:
Sílvia Saumell, Francesc Solé, Leonor Arenillas, Julia Montoro, David Valcárcel, Carme Pedro, Carmen Sanzo, Elisa Luño, Teresa Giménez, Montserrat Arnan, Helena Pomares, Raquel De Paz, Beatriz Arrizabalaga, Andrés Jerez, Ana B Martínez, Judith Sánchez-Castro, Juan D Rodríguez-Gambarte, José M Raya, Eduardo Ríos, María Rodríguez-Rivera, Blanca Espinet, Lourdes Florensa
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129375 (2015)
Isolated trisomy 8 is not considered presumptive evidence of myelodysplastic syndrome (MDS) in cases without minimal morphological criteria. One reason given is that trisomy 8 (+8) can be found as a constitutional mosaicism (cT8M). We tried to clarif
Externí odkaz:
https://doaj.org/article/1c729b629a2f4a5282a8ff5a03191030
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carmen De Ramón Ortiz, Raul Justo Sanz, Yan Beauverd, Karem Humala, Ana López de la Guia, Raquel De Paz, Mercedes Gasior, Pilar Gómez Prieto, Marta Fabra Urdiola, Miguel Canales Albendea, Nora Butta, Victor Jiménez Yuste
Publikováno v:
Disease Markers. 2023:1-9
Background. Sinusoidal obstructive syndrome (SOS) is a potentially fatal complication secondary to hematopoietic stem cell transplant (HSCT) conditioning. Endothelial damage plasma biomarkers such as plasminogen activator inhibitor-1 (PAI-1), hyaluro